Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 19 10 2020
revised: 16 02 2021
accepted: 23 02 2021
pubmed: 2 3 2021
medline: 21 5 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

The aim of this study was to identify the factors influencing the delay in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA negative conversion. A cohort study was conducted that included patients with coronavirus disease 2019 (COVID-19) admitted to the Tunisian national containment center. Follow-up consisted of a weekly RT-PCR test. Multivariate Cox regression analysis was performed to determine independent predictors associated with negative RNA conversion. Among the 264 patients included, the median duration of viral clearance was 20 days (interquartile range (IQR) 17-32 days). The shortest duration was 9 days and the longest was 58 days. Factors associated with negative conversion of viral RNA were symptoms such as fatigue, fever, and shortness of breath (hazard ratio (HR) 0.600, 95% confidence interval (CI) 0.401-0.897) and face mask use when exposed to COVID-19 cases (HR 2.006, 95% CI 1.247-3.228). The median time to RNA viral conversion was 18 days (IQR 16-21 days) when using masks versus 23 days (IQR 17-36 days) without wearing masks, and 24 days (IQR 18-36 days) for symptomatic patients versus 20 days (IQR 16-30 days) for asymptomatic patients. The results of this study revealed that during SARS-CoV-2 infection, having symptoms delayed viral clearance, while wearing masks accelerated this conversion. These factors should be taken into consideration for the strategy of isolating infected patients.

Identifiants

pubmed: 33647508
pii: S1201-9712(21)00175-2
doi: 10.1016/j.ijid.2021.02.089
pmc: PMC7910140
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

463-469

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Chest. 2020 Nov;158(5):1876-1884
pubmed: 32569635
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Apr 10;41(4):485-488
pubmed: 32141279
Int J Infect Dis. 2020 Jul;96:531-537
pubmed: 32425636
Sci Total Environ. 2020 Aug 1;728:138812
pubmed: 32335406
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
JAMA Intern Med. 2020 Nov 1;180(11):1447-1452
pubmed: 32780793
BMJ Open. 2020 Sep 2;10(8):e040380
pubmed: 32878768
Chest. 2013 Jan;143(1):196-206
pubmed: 23276842
J Infect. 2020 Jun;80(6):e14-e18
pubmed: 32171866
Influenza Other Respir Viruses. 2013 Sep;7(5):833-7
pubmed: 23279949
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Med Virol. 2021 Jan;93(1):506-512
pubmed: 32644223
J Infect Chemother. 2021 Jan;27(1):70-75
pubmed: 32950393
N Engl J Med. 2020 Oct 29;383(18):e101
pubmed: 32897661
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Hum Reprod Update. 2005 Jul-Aug;11(4):411-23
pubmed: 15817524
Exp Gerontol. 2007 May;42(5):400-6
pubmed: 17218073
J Gen Intern Med. 2020 Oct;35(10):3063-3066
pubmed: 32737790
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
J Infect Dis. 2020 Aug 17;222(6):910-918
pubmed: 32614392
Chin Med J (Engl). 2020 May 5;133(9):1039-1043
pubmed: 32118639
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563
Front Med (Lausanne). 2020 Aug 28;7:562
pubmed: 32984389

Auteurs

Cyrine Bennasrallah (C)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Department of Epidemiology, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia; Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, Monastir, Tunisia. Electronic address: cyrine.bennasrallah@gmail.com.

Imen Zemni (I)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Department of Epidemiology, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia; Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, Monastir, Tunisia. Electronic address: imen11zemni@gmail.com.

Wafa Dhouib (W)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Department of Epidemiology, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia; Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, Monastir, Tunisia. Electronic address: Wafa.dhouib20@yahoo.fr.

Haythem Sriha (H)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia. Electronic address: haythem.sriha92@gmail.com.

Nourhene Mezhoud (N)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia. Electronic address: nourhenemezhoud7@gmail.com.

Samar Bouslama (S)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia. Electronic address: bouslama.samar94@gmail.com.

Wael Taboubi (W)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia. Electronic address: wael1733@gmail.com.

Meriem Oumaima Beji (MO)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia. Electronic address: meriemoumaimabeji@gmail.com.

Meriem Kacem (M)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Department of Epidemiology, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia; Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, Monastir, Tunisia. Electronic address: merioumakacem@gmail.com.

Hela Abroug (H)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Department of Epidemiology, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia; Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, Monastir, Tunisia. Electronic address: hela-abr@hotmail.com.

Manel Ben Fredj (MB)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Department of Epidemiology, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia; Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, Monastir, Tunisia. Electronic address: manel-ben-fredj@hotmail.fr.

Chawki Loussaief (C)

Department of Infectiology, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia. Electronic address: prchawkiloussaief@gmail.com.

Asma Sriha Belguith (AS)

Department of Epidemiology and Preventive Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Department of Epidemiology, Faculty of Medicine of Monastir, University of Monastir, Monastir, Tunisia; Technology and Medical Imaging Research Laboratory - LTIM - LR12ES06, Monastir, Tunisia. Electronic address: belguith_asma@yahoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH